X Genomics Inc . (NASDAQ:TXG) reported its Q4 2024 earnings, revealing a larger-than-expected loss per share and a decline in revenue compared to the previous year. The company posted an EPS of -$0.40 ...
Significant Trading Growth: PINTU’s trading volume surged over 150% YoY from January 2024 to January 2025, with Monthly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback